These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1421 related items for PubMed ID: 10560951

  • 21. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay.
    Inui T, Kouki T, Yamashiro K, Hachiya T, Ochi Y, Kajita Y, Sato Y, Nagata A.
    Thyroid; 1998 Apr; 8(4):319-25. PubMed ID: 9588497
    [Abstract] [Full Text] [Related]

  • 22. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC, Buiting AM, Karperien M, Ballieux BE, van der Pluijm G, Pereira AM, Romijn JA, Smit JW.
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
    [Abstract] [Full Text] [Related]

  • 23. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism.
    Takasu N, Yamashiro K, Ochi Y, Sato Y, Nagata A, Komiya I, Yoshimura H.
    Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928
    [Abstract] [Full Text] [Related]

  • 24. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies.
    Akamizu T, Mori T, Kasagi K, Kosugi S, Miyamoto M, Nishino K, Sugawa H, Yokota T, Nakamura H, Konishi J.
    Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clinical usefulness of thyroid-stimulating antibody measurement using Chinese hamster ovary cells expressing human thyrotropin receptors.
    Murakami M, Miyashita K, Kakizaki S, Saito S, Yamada M, Iriuchijima T, Takeuchi T, Mori M.
    Eur J Endocrinol; 1995 Jul; 133(1):80-6. PubMed ID: 7627342
    [Abstract] [Full Text] [Related]

  • 29. Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.
    Akamizu T, Kohn LD, Hiratani H, Saijo M, Tahara K, Nakao K.
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2116-21. PubMed ID: 10852437
    [Abstract] [Full Text] [Related]

  • 30. Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies.
    Kim WB, Chung HK, Park YJ, Park DJ, Lee HK, Cho BY.
    Korean J Intern Med; 2001 Sep; 16(3):187-200. PubMed ID: 11769578
    [Abstract] [Full Text] [Related]

  • 31. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
    Mori Y, Matoba N, Miura S, Sakai N, Taira Y.
    World J Surg; 1992 Sep; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
    [Abstract] [Full Text] [Related]

  • 32. Sensitive assay to detect thyroid stimulating antibody (TSAb) in the presence of thyroid stimulation blocking antibody (TSBAb) in serum.
    Ochi Y, Yamashiro K, Takasu N, Kajita Y, Sato Y, Nagata A.
    Horm Metab Res; 2001 Feb; 33(2):115-20. PubMed ID: 11294493
    [Abstract] [Full Text] [Related]

  • 33. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S, Ban T, Akamizu T, Kohn LD.
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [Abstract] [Full Text] [Related]

  • 34. Comparison of thyroid stimulating activities measured by cyclic AMP production, those by radioiodine uptake in FRTL-5 cells and TSH-binding inhibitory activities in patients with hyperthyroid and euthyroid Graves' diseases.
    Kasagi K, Hatabu H, Tokuda Y, Arai K, Iida Y, Konishi J.
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):365-72. PubMed ID: 2898192
    [Abstract] [Full Text] [Related]

  • 35. A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs.
    Kawai K, Tamai H, Matsubayashi S, Mukuta T, Morita T, Kubo C, Kuma K.
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):551-6. PubMed ID: 8548939
    [Abstract] [Full Text] [Related]

  • 36. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H, Kasagi K, Morita T, Hidaka A, Kuma K, Konishi J, Kumagai LF, Nagataki S.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical significance of a sensitive assay for thyroid-stimulating antibodies in Graves' disease using polyethylene glycol at high concentrations and porcine thyroid cells.
    Kamijo K, Nagata A, Sato Y.
    Endocr J; 1999 Jun; 46(3):397-403. PubMed ID: 10503992
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 72.